Articles tagged with Vaccination
A new study by the American Society of Animal Science found that adult horses with low selenium levels have suppressed cell-mediated immunity, while antibody production remained unaffected. The researchers aimed to understand how different levels of selenium affect the immune system in horses.
A new vaccine has shown promise in boosting the immune system's ability to attack leukemia cells in post-transplant patients. The personalized tumor vaccine, which includes the patient's own irradiated leukemia cells combined with an immune stimulant, has been shown to induce a strong and selective immune response.
A clinical trial found that tumor cell vaccination increased complete remission rates and induced leukemia-specific T-cells in patients with advanced Chronic Lymphocytic Leukemia (CLL). The study suggests that this approach may enhance anti-tumor responses following allo-HSCT.
A new modular vaccine design called MAPS technology may generate vaccines conferring strong immunity at reduced cost and risk. The method allows for rapid construction of new vaccines that activate multiple arms of the immune system simultaneously against one or more pathogens, reducing the risk of adverse effects.
IDRI's VL vaccine candidate has shown safety and immunogenicity in healthy volunteers, and Zydus' expertise will be crucial in getting the vaccine to those who need it most. The partnership aims to make the vaccine affordable and accessible to all people in need, particularly in endemic countries.
Research by UNSW academics links human papillomavirus (HPV) to an increased risk of esophageal squamous cell carcinoma, a type of oesophageal cancer. HPV is one of several factors contributing to the development of OSCC, which is more prevalent in certain countries like China, South Africa, and Iran.
A new study from University of Toronto Professor Peter A. Newman reveals that vaccinating boys aged 11-21 is crucial for reducing cancer rates across sexes. The lack of a well-established connection between HPV in men and life-threatening illnesses hinders male vaccination rates.
A study by Columbia Nursing researchers found that automated reporting of immunization data through EHRs increased knowledge about individuals and communities, allowing medical and public health officials to make informed decisions. This led to reduced lag times, improved documentation, and enhanced efficiency in vaccine tracking.
A clinical trial assessing an anti-melanoma vaccine found that it enhances the effectiveness of the immune system by increasing IL-12p70 production. Six out of seven patients exhibited a vaccine-stimulated immune response, with three showing clinically significant changes in tumor progression.
Researchers at the University of British Columbia have developed a vaccine to protect birds against West Nile Virus (WNV), which has killed over 300 people in North America. The vaccine, made from WNV components, generated an effective immune response in birds and may also offer protection against other species.
Less than one third of obstetrician-gynecologists vaccinate patients against HPV, while only half follow cervical cancer prevention guidelines. Physician-patient interactions are a major barrier to guideline implementation.
A study by NYU Langone researchers found that states with simpler vaccination exemption processes have higher non-medical exemption rates, contributing to outbreaks of childhood infections. States with looser requirements are more likely to see parents opt-out of vaccinating their children, putting others at risk.
A cancer doctor turned to immunotherapy after his Great Dane's lung cancer diagnosis. The treatment, using an engineered vaccine, significantly prolonged the dog's life and has sparked interest in testing on human brain cancer patients.
Researchers have developed a novel vaccination method using gold nanoparticles that can deliver specific proteins to the body's immune cells. The technique mimics viruses and stimulates an immune response, offering significant safety advantages.
Researchers at University of Helsinki and ETH Zurich have solved the three-dimensional structure of RSV, a common cause of respiratory infection. The structural model provides valuable information for intelligent vaccine design, targeting the virus's fusion protein and matrix protein.
Researchers have developed a vaccine that provides at least 60 percent protection against rotavirus in newborns, significantly reducing severe dehydration and hospitalizations. The study, published in the Journal of Infectious Diseases, suggests that early administration of the vaccine could save thousands of lives annually.
A new study on an anti-nicotine vaccination found mixed results, with some patients experiencing a decrease in brain nicotine accumulation but others showing an increase. The study used PET imaging to test the vaccine's effectiveness, revealing that high-affinity antibodies were associated with decreased brain nicotine accumulation.
Researchers have created a powerful digital system, SALSA, to analyze billions of tweets and social media messages in just seconds. The tool helps emergency responders receive early information about natural disasters and public health advocates protect people's health by identifying valuable patterns amidst vast amounts of noise.
The first-ever enterovirus 71 vaccine has been shown to be highly effective in protecting young children against the potentially deadly hand, foot, and mouth disease. The vaccine demonstrated 90% protection against clinical EV71-associated HFMD and 80.4% against EV71-associated disease for at least 12 months.
Researchers at the University of Exeter have developed a vaccine that protects against necrotic enteritis, a severe poultry disease caused by Clostridium perfringens. The vaccine targets the bacterium's NetB toxin, allowing for effective prevention and control of the devastating disease.
A new 13-valent pneumococcal conjugate vaccine (PCV13) has been found to be as safe as the previously used 7-valent PCV7, according to a Kaiser Permanente study. The vaccine protects against a broader range of pneumococcal types and provides protection against serious infections such as meningitis.
A new oral vaccine against ETEC has been developed and shown to be safe and highly immunogenic in a phase I study, inducing immune responses in all volunteers. The vaccine is designed to protect travelers and children living in areas endemic for ETEC.
A new Kaiser Permanente study published in Pediatrics found that whole-cell pertussis vaccines were more effective at protecting against pertussis than acellular pertussis vaccines during a large recent outbreak in California. The study examined 138 individuals with confirmed pertussis and found that teenagers vaccinated with four dose...
A University of Michigan-led study challenges prevailing theories on whooping cough's resurgence by showing vaccines offer long-lived protection and reduced transmission. The study highlights the success of Thailand's childhood immunization program in reducing pertussis cases, especially among infants.
A new global surveillance tool detects and monitors public concerns about vaccines, allowing for swift responses to prevent low vaccine uptake and disease outbreaks. The tool analyzes reports from 144 countries, identifying key themes and prioritizing action to promote immunisation.
Researchers at Weill Cornell Medical College have developed an anti-cocaine vaccine that prevents the drug from reaching the brain and producing a high. The vaccine works by generating antibodies against cocaine, rendering it ineffective, and has shown promising results in non-human primates.
A new engineered protein from a reaper spider's venom may offer a promising candidate for therapeutic serums or vaccination against other venoms. The protein provides effective protection against the effects of pure spider venom in animal models.
Researchers identified genetic differences in 27 genes responsible for antigen interactions, inflammation, and gene pathways involved between high and low responders. The study provides insights into developing alternative vaccines for individuals who do not respond effectively to the standard rubella vaccine.
A recent study found that immune responses to HPV-16 and HPV-18 infection were noninferior in girls receiving two doses of the HPV vaccine compared to those receiving three doses. The study suggests a possible reduced-dose schedule for HPV vaccination, which could improve vaccine uptake rates and reduce costs.
A new vaccine candidate for post-operative staph infections failed to demonstrate efficacy in reducing serious infections and was associated with increased mortality among patients who developed the infection. The study found no significant difference in efficacy between the vaccine and placebo groups, and reported a higher rate of mul...
Researchers found no association between vaccine exposure and autism in a study of over 300 children with ASD and 750 without, contradicting long-standing parental concerns about vaccine safety.
A new study by Michigan State University found that about four percent of HIV-positive individuals also have hepatitis, highlighting the need for stronger protections against co-infection. The study reveals that behaviors putting people at risk of HIV also increase their risk of getting hepatitis B or C.
Researchers at the University of Texas Medical Branch have developed a safe and simple Chagas disease vaccine candidate, TcVac3, which shows over 90 percent protection against chronic infection in mice. The potential vaccine could be approved in as few as five years for use in canines, who are reservoir hosts of the disease.
The Third Global Forum on TB Vaccines brings together researchers and stakeholders to review progress and discuss strategies to advance the field. New research suggests that novel vaccines for adolescents and adults could significantly reduce TB cases and deaths in high-burden countries by 2050.
African experts argue that immunization systems are failing due to issues with vaccine supply, financing, and sustainability. The authors call for strengthened programs to address regional and country-specific problems and develop precise strategies to overcome challenges.
A Loyola University Chicago study found that disabling a specific calcium channel called TRPM2 could reduce painful inflammation in gout. The researchers also discovered that liposomes with a positive or negative electric charge can stimulate the immune system to attack pathogens.
A recent study by Mayo Clinic found that over 2 in 5 parents are hesitant to vaccinate their teenage daughters against human papillomavirus (HPV) due to potential side effects. The vaccine is recommended for teens to prevent cervical cancer and genital cancers, with the majority of experts agreeing on its necessity.
A recent study by the European Association of Urology has shown promising results for a combined vaccine and steroid drug therapy in treating chemotherapy-naive castration-resistant prostate cancer (CRPC). The therapy, which involves multi-peptide vaccination therapy with low-dose dexamethasone, has been shown to significantly improve ...
New research from the University of Texas Medical Branch reveals staggering low HPV vaccine uptake rates among females and males across various age groups and socio-economic spectrums. The studies suggest inadequate knowledge, lack of physician recommendation, and negative beliefs about vaccines as major hindrances.
Researchers from Cardiff University and La Jolla Institute have identified a previously unknown cellular mechanism that could prove critical in creating a CMV vaccine. This discovery sheds light on the virus's stealthy nature and its ability to evade immune detection.
A Swedish national registry study found that HPV vaccination before age 14 significantly reduced the incidence of genital warts in girls. The study also revealed socioeconomic disparities in vaccination rates, with higher educated parents more likely to vaccinate their daughters.
A new study by UCSF researchers reveals that T cells gather together and share information, helping to mount a coordinated response to invading pathogens. The discovery sheds light on the mechanism behind vaccine effectiveness, which relies on T-cell aggregation to form long-term memory.
A team of researchers from La Jolla Institute and Cardiff University has identified a novel cellular mechanism that could aid in creating a CMV vaccine. The study found that a specific CMV protein blocks the ability of immune pathways to kill infected cells, providing an important piece of the CMV puzzle.
Researchers at the University of Southampton have identified a potential new target for meningitis B vaccination, offering hope for universal protection. The discovery focuses on the Adhesin Complex Protein (ACP), which stimulates the production of antibodies that kill bacteria, providing protection against multiple MenB strains.
A new study reveals that the bladder is unable to mount an effective immune response to bacteria, leading to recurrent infections. The researchers found that mast cells produce interleukin-10, which drives localized immune tolerance in chronic bladder infection.
The Vanderbilt-led research found that human metapneumovirus is the second leading cause of severe bronchiolitis in young children, affecting more children over age 1 than RSV. The study provides a clearer picture of how this virus impacts children and highlights the need for vaccines to prevent it.
Scientists at Imperial College London have discovered a new way to treat Respiratory Syncytial Virus (RSV) infections in children. By boosting the accumulation of T cells and selectively attracting regulatory T cells, they aim to reduce inflammation and fight infection.
A two-step personalized immunotherapy treatment using dendritic cell vaccine and adoptive T cell therapy has triggered anti-tumor immune responses in patients with late-stage ovarian cancer. Four of six patients treated responded to the therapy, showing promising early results.
A BUSM study found that low-income and minority parents/guardians are inclined to accept HPV vaccination for boys with the aim of protecting them from cancer and other diseases. However, racial/ethnic differences emerged in attitudes regarding school-entry mandates.
A Kaiser Permanente study found that nearly half of children under 2 years old did not receive all recommended vaccinations. Children who missed scheduled vaccines were more likely to be admitted to hospitals and have fewer doctor visits than those vaccinated on time.
A mass poultry vaccination programme has been credited with a significant decline in Salmonella cases, from 1.6 cases per 1,000 person years in 1993-96 to 0.2 cases per 1,000 person years in 2008-09. The number of laboratory-confirmed cases dropped from over 18,000 in 1993 to just 459 in 2010.
Researchers at Université Laval have identified a molecule that stimulates the activity of the brain's immune cells, which could lead to a treatment and vaccine for Alzheimer's disease. Weekly injections of MPL eliminated up to 80% of senile plaques in mice with Alzheimer's symptoms, improving cognitive function.
Researchers Seung Mun You and Hyejin Moon are using aluminum and nanopore technology to update an ancient evaporative process, known as zeer cooling, to cool vaccines and medicine without electricity. Their goal is to preserve vaccines and medicines in remote areas with limited access to electricity.
A recent study found that many teenagers who received a complete hepatitis B vaccine series as infants can still contract the virus, especially if they have high-risk mothers or weak immune systems. Researchers suggest that a booster shot at age 15 may be necessary to prevent reinfection.
A study published in the Journal of the National Cancer Institute found that HPV-associated cancer incidence rates have increased, highlighting the need for increased HPV vaccination coverage. Nationally, 32% of females aged 13-17 years had received three doses of the HPV vaccine in 2010.
A study published in the American Journal of Public Health found that timely reminders from state or local health departments are more effective at increasing immunization rates among preschool children than those from primary care practices. The study suggests that partnerships between public health departments and primary care provid...
The Johns Hopkins Bloomberg School will provide relief agencies and governments with technical assistance on using oral cholera vaccine. The DOVE program aims to detect outbreaks in remote areas and contain the disease, improving global efforts to combat cholera.
Researchers at Universitat Autonoma de Barcelona have developed a vaccine against human leishmaniasis that shows promising results, offering new hope for the fight against this devastating disease. The vaccine combines DNA and protein-based approaches, using insect larvae to produce the proteins at low cost.
Researchers discovered a mechanism by which Ebola virus alters and evades the immune response of its infected host. The secreted protein can selectively drive induction of antibody responses to itself while competing for antibodies to the viral surface protein, enabling repeated or sustained infection.
A four-year field study shows BCG vaccination reduces TB infection risk in unvaccinated badger cubs in vaccinated groups and social groups. Vaccination can indirectly protect cubs before they emerge from their setts.